Burgaz, S.; GarcÃa, C.; Gonzalo-Consuegra, C.; Gómez-AlmerÃa, M.; Ruiz-Pino, F.; Unciti, J.D.; Gómez-Cañas, M.; Alcalde, J.; Morales, P.; Jagerovic, N.;
et al. Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis. Molecules 2021, 26, 7643.
https://doi.org/10.3390/molecules26247643
AMA Style
Burgaz S, GarcÃa C, Gonzalo-Consuegra C, Gómez-AlmerÃa M, Ruiz-Pino F, Unciti JD, Gómez-Cañas M, Alcalde J, Morales P, Jagerovic N,
et al. Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis. Molecules. 2021; 26(24):7643.
https://doi.org/10.3390/molecules26247643
Chicago/Turabian Style
Burgaz, Sonia, Concepción GarcÃa, Claudia Gonzalo-Consuegra, Marta Gómez-AlmerÃa, Francisco Ruiz-Pino, Juan Diego Unciti, MarÃa Gómez-Cañas, Juan Alcalde, Paula Morales, Nadine Jagerovic,
and et al. 2021. "Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis" Molecules 26, no. 24: 7643.
https://doi.org/10.3390/molecules26247643
APA Style
Burgaz, S., GarcÃa, C., Gonzalo-Consuegra, C., Gómez-AlmerÃa, M., Ruiz-Pino, F., Unciti, J. D., Gómez-Cañas, M., Alcalde, J., Morales, P., Jagerovic, N., RodrÃguez-Cueto, C., de Lago, E., Muñoz, E., & Fernández-Ruiz, J.
(2021). Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis. Molecules, 26(24), 7643.
https://doi.org/10.3390/molecules26247643